CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/17924835

Download in:

View as

General Info

PMID
17924835